Explore more publications!
New Jersey Business Journal
Got News to Share?

New Jersey Business Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Business Journal.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on September 29, 2025

Comprehensive Guide Reveals How Heat Pumps Deliver 20–40 % Energy Savings and Dual Heating & Cooling
September 29, 2025

Comprehensive Guide Reveals How Heat Pumps Deliver 20–40 % Energy Savings and Dual Heating & Cooling

Indeterminate EIN Presswire
ClassGaga Announces Fall 2025 Math Learning Grant Recipients, Expanding AI-Powered Support for Schools Nationwide
September 29, 2025

ClassGaga Announces Fall 2025 Math Learning Grant Recipients, Expanding AI-Powered Support for Schools Nationwide

Indeterminate EIN Presswire
Patriot Property Buyer: Veteran-Owned Real Estate Company Redefines Home Selling with Service, Integrity, and Impact
September 29, 2025

Patriot Property Buyer: Veteran-Owned Real Estate Company Redefines Home Selling with Service, Integrity, and Impact

Indeterminate EIN Presswire
Spiro Harrison & Nelson Welcomes Veteran Affordable Housing Litigator Michael A. Jedziniak
September 29, 2025

Spiro Harrison & Nelson Welcomes Veteran Affordable Housing Litigator Michael A. Jedziniak

Indeterminate EIN Presswire
Refunzo Drives $15,600 FBA Reimbursements Recovery for Kitchen Tools Brand in 30 Days
September 29, 2025

Refunzo Drives $15,600 FBA Reimbursements Recovery for Kitchen Tools Brand in 30 Days

Indeterminate EIN Presswire
OTCM Protocol Introduces Security Meme Tokens: The Solution to America's $50 Billion OTC Liquidity Crisis
September 29, 2025

OTCM Protocol Introduces Security Meme Tokens: The Solution to America's $50 Billion OTC Liquidity Crisis

Indeterminate EIN Presswire
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

Indeterminate GlobeNewswire
Fiberglass Market worth $34.97 billion by 2030, at a CAGR of 5.2%, says MarketsandMarkets™
September 29, 2025

Fiberglass Market worth $34.97 billion by 2030, at a CAGR of 5.2%, says MarketsandMarkets™

Indeterminate GlobeNewswire
Artelo Biosciences Announces Proposed Underwritten Public Offering
September 29, 2025

Artelo Biosciences Announces Proposed Underwritten Public Offering

Indeterminate GlobeNewswire
RCI Hospitality Holdings, Inc. (RICK) Faces Investor Class Action Amid Sell-Off After Tax Fraud Indictment Against Company, CEO, & CFO -- Hagens Berman
September 29, 2025

RCI Hospitality Holdings, Inc. (RICK) Faces Investor Class Action Amid Sell-Off After Tax Fraud Indictment Against Company, CEO, & CFO -- Hagens Berman

Indeterminate GlobeNewswire
Prime Mining Securityholders Approve Transaction with Torex Gold
September 29, 2025

Prime Mining Securityholders Approve Transaction with Torex Gold

Indeterminate GlobeNewswire
Gen Z Leads the Superfan Revival Through Community, Costumes, and Tattoos
September 29, 2025

Gen Z Leads the Superfan Revival Through Community, Costumes, and Tattoos

Indeterminate GlobeNewswire
Purpose Investments Inc. Announces 2025 Third Quarter Distributions for Purpose Specialty Lending Trust
September 29, 2025

Purpose Investments Inc. Announces 2025 Third Quarter Distributions for Purpose Specialty Lending Trust

Indeterminate GlobeNewswire
Purpose Investments Inc. annonce les distributions du troisième trimestre de 2025 pour la Fiducie de prêts spécialisés Purpose
September 29, 2025

Purpose Investments Inc. annonce les distributions du troisième trimestre de 2025 pour la Fiducie de prêts spécialisés Purpose

Indeterminate GlobeNewswire
NEXE Innovations Reports Q4 and Fiscal 2025 Results; Expands Partnerships, Delivers Repeat Orders, and Maintains Strong Financial Position
September 29, 2025

NEXE Innovations Reports Q4 and Fiscal 2025 Results; Expands Partnerships, Delivers Repeat Orders, and Maintains Strong Financial Position

Indeterminate GlobeNewswire
Carbon Streaming Announces Receipt of Settlement Funds and Share Cancellation Pursuant to Settlement Agreement Related to Rimba Raya Project
September 29, 2025

Carbon Streaming Announces Receipt of Settlement Funds and Share Cancellation Pursuant to Settlement Agreement Related to Rimba Raya Project

Indeterminate GlobeNewswire
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SVRA
September 29, 2025

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– SVRA

Indeterminate GlobeNewswire
Altai Announces Sale of Cessford Oil Wells Property
September 29, 2025

Altai Announces Sale of Cessford Oil Wells Property

Indeterminate GlobeNewswire
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC
September 29, 2025

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC

Indeterminate GlobeNewswire
NANOBIOTIX annonce de nouveaux résultats de Phase 1 qui continuent de confirmer le potentiel de JNJ-1900 (NBTXR3), avec un anti-PD-1, en tant que potentielle nouvelle option thérapeutique de première ou deuxième ligne ou plus dans le CETEC R/M naïf ou …
September 29, 2025

NANOBIOTIX annonce de nouveaux résultats de Phase 1 qui continuent de confirmer le potentiel de JNJ-1900 (NBTXR3), avec un anti-PD-1, en tant que potentielle nouvelle option thérapeutique de première ou deuxième ligne ou plus dans le CETEC R/M naïf ou …

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions